{"gao_id": "GAO-18-140", "published": "2017-12-15T12:00:00Z", "released": "2018-01-16T07:00:00Z", "summary": "FDA regulates medical devices to ensure they are safe and effective, and relies on the organization sponsoring the device (usually the manufacturer) to provide the relevant information when the device is submitted for review. FDA is required to use a \u201cleast burdensome\u201d approach in its review of medical devices, including when it requests additional information from sponsors. We looked at FDA\u2019s implementation of the least...", "title": "FDA Medical Device Reviews: Evaluation is Needed to Assure Requests for Additional Information Follow a Least Burdensome Approach", "topics": ["Manufacturing", "User fees", "Health Care", "Audit objectives", "Health care standards", "Medical devices", "Agency evaluations", "Quality assurance", "Internal controls", "Performance goals", "Compliance oversight"], "type": "reports-testimonies", "url": "https://www.gao.gov/products/gao-18-140", "versions": [{"title": "Highlights Page (1 page)", "url": "https://www.gao.gov/assets/gao-18-140-highlights.pdf"}, {"title": "Full Report (41 pages)", "url": "https://www.gao.gov/assets/gao-18-140.pdf"}, {"title": "Accessible PDF (50 pages)", "url": "https://www.gao.gov/assets/690/689645.pdf"}]}